Details
Product Name in the RMS: Emerpand
MR Number: DK/H/2329/002
Date of outcome: 25.11.2014
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Additional Strength/Form Generic Chemical Substance Prescription Only |
Active Substances |
rivastigmine 4,6 mg/24h |
Form | Transdermal patch |
MA Holder in the RMS |
Splitting procedure: New splitted procedure numbers are IE/H/0569/001-003, SI/H/0183/001-003 and PT/H/2144/001-003 Actavis Group PTC ehf. Reykjavíkurvegur 76-78 220 Hafnarfjödur Iceland |
RMS | Denmark |
Date of last change | 28.10.2019 |
ATC-Code |
N06DA03 Rivastigmine |
CMS Country | Domestic Product Name |
---|---|
Norway |
Documents | |
---|---|
PAR: | DK_H_2329_002_PAR.pdf (05.11.2015) |
PARSummary: | DK_H_2329_002_PARSummary.pdf (05.11.2015) |
FinalLabelling: | DK_H_2329_002_FinalLabelling.pdf (06.11.2018) |
Finalised Product Information: | DK_H_2329_002_FinalPI.pdf (08.12.2014) |